New application of nitro-styrene derivatives in inhibition of fructose-1,6-bisphosphatase
A technology of nitrostyrene and diphosphatase, applied in the direction of active ingredients of nitro compounds, active ingredients of hydroxyl compounds, medical preparations containing active ingredients, etc., can solve the problem of not reducing antidiabetic drugs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach
[0018] In order to illustrate that such nitrostyrene compounds do have a good inhibitory effect on the target enzyme fructose-1,6-bisphosphatase that can be used to treat type II diabetes, we carried out enzymatic tests on the above compounds, and the specific implementation methods are as follows:
[0019] Fructose-1,6-bisphosphatase is an important regulatory enzyme of gluconeogenesis in the human body, which can catalyze the hydrolysis of fructose-1,6-bisphosphate into fructose-6-phosphate and inorganic phosphate. Inorganic phosphoric acid can form a blue-green complex with a mixture of basic dye malachite green and ammonium molybdate in the presence of polyhexenol. The reaction system is 50mM Tric-HCl pH7.4, 0.8mM MgCl 2 , FBPase11.2μg / ml, 0.4mM FBP (fructose-1,6-bisphosphate), appropriate concentration gradient inhibitors (compounds numbered below), enzymatic hydrolysis at 37°C for 5min, and 1M perchloric acid to terminate the enzymatic reaction , using the endpoint meth...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com